Novo reinvested in the surgical tool maker as it closed a debt and equity round that will be used to commercialise its product.

Non-profit seed investor Bridge to Cures launches in Wisconsin to support life science spin-outs.

The wearable medical technology developer has been purchased by Covidien, granting exits to corporate investors Motorola Solutions and 3M.

Anokion, which is developing treatments for autoimmune diseases and allergies, is planning the first clinical trials of its treatments in 2017.

Boston Scientific, which originally held a 28% stake, will acquire gynecological surgery product technology developer IoGyn, with their products to be integrated.